A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis
NCT01363713 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 130
Last updated 2014-10-06
Summary
Safety and efficacy of DE-114 ophthalmic solution will be evaluated in patients with allergic conjunctivitis, in an open-label, multicenter study.
Conditions
- Allergic Conjunctivitis
Interventions
- DRUG
-
DE-114 ophthalmic solution
Sponsors & Collaborators
-
Santen Pharmaceutical Co., Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Primary Completion
- 2012-09-30
Countries
- Japan
Study Locations
More Related Trials
-
Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects
NCT00987272 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
NCT00423007 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis
NCT00241319 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine
NCT01179412 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops in the Treatment of Chinese Seasonal Allergic Conjunctivitis Patients
NCT06212973 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes
NCT03846453 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis
NCT01732757 ·Status: COMPLETED ·Phase: PHASE4
-
Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis
NCT01289431 ·Status: COMPLETED ·Phase: PHASE2
-
Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01189032 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model
NCT01479374 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis
NCT01272089 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease
NCT03216096 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01468168 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1 Study for Safety and Tolerability of IL-1-Ra Topically Administered to Eyes of Healthy Adult Subjects
NCT03383276 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis
NCT01470118 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis
NCT00364091 ·Status: COMPLETED ·Phase: PHASE3
-
AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis
NCT02161146 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis
NCT01743027 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis
NCT00244543 ·Status: COMPLETED ·Phase: PHASE3
-
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01118754 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults
NCT05969236 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis
NCT02079649 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis
NCT05579730 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients
NCT01109485 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry Eye
NCT05109702 ·Status: COMPLETED ·Phase: PHASE3